Cited by 575Luminescence Properties of Advanced MaterialsNanoplatforms for cancer theranosticsOptical Imaging and Spectroscopy Techniques

In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles

Open access
Zhong, Yeteng, Ma, Zhuoran, Wang, Feifei, Wang, Xi, Yang, Yijun, Liu, Yulai, Zhao, Xiang, Li, Jiachen +11 more·2019·Nature Biotechnology

Abstract

The near-infrared-IIb (NIR-IIb) (1,500-1,700 nm) window is ideal for deep-tissue optical imaging in mammals, but lacks bright and biocompatible probes. Here, we developed biocompatible cubic-phase (α-phase) erbium-based rare-earth nanoparticles (ErNPs) exhibiting bright downconversion luminescence at ~1,600 nm for dynamic imaging of cancer immunotherapy in mice. We used ErNPs functionalized with cross-linked hydrophilic polymer layers attached to anti-PD-L1 (programmed cell death-1 ligand-1) antibody for molecular imaging of PD-L1 in a mouse model of colon cancer and achieved tumor-to-normal tissue signal ratios of ~40. The long luminescence lifetime of ErNPs (~4.6 ms) enabled simultaneous imaging of ErNPs and lead sulfide quantum dots emitting in the same ~1,600 nm window. In vivo NIR-IIb molecular imaging of PD-L1 and CD8 revealed cytotoxic T lymphocytes in the tumor microenvironment in response to immunotherapy, and altered CD8 signals in tumor and spleen due to immune activation. The cross-linked functionalization layer facilitated 90% ErNP excretion within 2 weeks without detectable toxicity in mice.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-019-0262-4

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhong, Y., Ma, Z., Wang, F., Wang, X., Yang, Y., Liu, Y., Zhao, X., Li, J., Du, H., Zhang, M., Cui, Q., Zhu, S., Sun, Q., Wan, H., Tian, Y., Liu, Q., Wang, W., Garcia, K. C., & Dai, H.
Affiliations
  • Stanford University (US)
  • Beijing Jiaotong University (CN)
  • Stanford Medicine (US)
Corresponding author
Dai, Hongjie
Venue
Nature Biotechnology
Published
2019-09-30
Volume
37
Issue
11
Pages
1322-1331
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W2975715205
Cited by
575
References
59
Citations by year
2026: 32 · 2025: 83 · 2024: 78 · 2023: 109 · 2022: 107 · 2021: 101 · 2020: 60 · 2019: 4
FWCI
24.54
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
U.S. Department of Health & Human Services | National Institutes of Health (DP1-NS-105737)
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence Properties of Advanced Materials
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
Keywords
rare earth nanoparticles, down-conversion luminescence, cancer immunotherapy, PD-L1 imaging, PD-L1 inhibitors, colon cancer, cytotoxic T lymphocytes, CD8, tumor microenvironment, PbS quantum dots, nanoparticle biocompatibility, nanoparticle clearance
MeSH terms
Antineoplastic Agents, Immunological, Animals, Colonic Neoplasms, Erbium, Immunotherapy, Infrared Rays, T-Lymphocytes, Cytotoxic, CD8 Antigens, Xenograft Model Antitumor Assays, Quantum Dots, Cell Line, Tumor, Mice, Nanoparticles, Tumor Microenvironment, B7-H1 Antigen, Optical Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review